Cargando…

Mesalamine Intolerance in Three Children with Crohn's Disease

OBJECTIVE: To present the mesalamine-induced acute exacerbation of symptoms and inflammatory markers in children with Crohn's disease (CD). CLINICAL PRESENTATION AND INTERVENTION: Three children who presented with CD had acute exacerbation of colitis symptoms or elevated inflammatory markers wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tuna Kirsaclioglu, Ceyda, Kuloglu, Zarife, Ustundag, Gonca, Kansu, Aydan, İnce, Erdal, Ensari, Arzu, Girgin, Nurten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588373/ https://www.ncbi.nlm.nih.gov/pubmed/26630041 http://dx.doi.org/10.1159/000442946

Ejemplares similares

Celiac Disease: Presentation of 109 Children
por: Kuloğlu, Zarife, et al.
Publicado: (2009)

Not all enteropathies are coeliac disease! Report of an infant with microvillus inclusion disease
por: Kozan, Eda Nur, et al.
Publicado: (2023)

Subclinical Cardiac Dysfunction in Children with Coeliac Disease: Is the Gluten-Free Diet Effective?
por: Saylan, Berna, et al.
Publicado: (2012)

Celiac Disease and Autoimmune Thyroid Disease in Children with Type 1 Diabetes Mellitus: Clinical and HLA−Genotyping Results
por: Ergür, Ayça Törel, et al.
Publicado: (2010)

Multiple Presentations of LRBA Deficiency: a Single-Center Experience
por: Kostel Bal, Sevgi, et al.
Publicado: (2017)

The frequency of Duchenne muscular dystrophy/Becker muscular dystrophy and Pompe disease in children with isolated transaminase elevation: results from the observational VICTORIA study
por: Kansu, Aydan, et al.
Publicado: (2023)

The culprit of mesalamine intolerance: case series and literature review
por: Xie, Cheng, et al.
Publicado: (2019)

Retrospective investigation of mesalamine intolerance in patients with ulcerative colitis
por: Minagawa, Yuki, et al.
Publicado: (2022)

A Rare Case of “Periportal Cuffing” as an Incidental Finding on (18)F-FDG PET/CT
por: Demir, Burak, et al.
Publicado: (2023)

Tacrolimus toxicity-related chorea in an infant after liver transplantation
por: Kahveci, Fevzi, et al.
Publicado: (2022)

Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn's Disease
por: Kwak, Min Seob, et al.
Publicado: (2018)

Natural History of Pediatric Patients With Crohn’s Disease Treated With Mesalamine Therapy
por: Young, Denise D., et al.
Publicado: (2023)

Response to Anastrozole Treatment in a Case with Peutz-Jeghers Syndrome and a Large Cell Calcifying Sertoli Cell Tumor
por: Yekedüz, Merve Koç, et al.
Publicado: (2017)

Current Trends in Tolerance Induction in Cow's Milk Allergy: From Passive to Proactive Strategies
por: Sackesen, Cansin, et al.
Publicado: (2019)

Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn’s disease
por: Doherty, Glen A, et al.
Publicado: (2009)

Intrahepatic cholestasis in Bruton's agammaglobulinemia receiving mesalamine for co-morbid Crohn's disease
por: Actis, Giovanni Clemente, et al.
Publicado: (2014)

The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country
por: Toy, Mehlika, et al.
Publicado: (2012)

Nephrotic syndrome after treatment of Crohn's disease with mesalamine: Case report and literature review
por: Firwana, Belal M., et al.
Publicado: (2012)

Patterns and Grading of Gastrointestinal Graft-Versus-Host Disease: A Clinicopathologic Correlation Study
por: Kuş Öztürk, Sonay, et al.
Publicado: (2023)

Mesalamine-Induced Myocarditis
por: Merceron, Olivier, et al.
Publicado: (2010)

Mesalamine Associated Bradycardia
por: Krzyzak, Michael, et al.
Publicado: (2018)

Mesalamine induced eosinophilic pneumonia
por: Gupta, Ankit, et al.
Publicado: (2017)

Transaldolase haploinsufficiency in subjects with acetaminophen‐induced liver failure
por: Oaks, Zachary, et al.
Publicado: (2020)

The role of mesalamine in the treatment of ulcerative colitis
por: Karagozian, Raffi, et al.
Publicado: (2007)

Gastric Pharmacobezoar of Mesalamine Tablets Retrieved Endoscopically
por: Sultania, Surender, et al.
Publicado: (2017)

Oral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications
por: Richter, James M., et al.
Publicado: (2016)

Recurrent Pericarditis: A Rare Adverse Effect of Mesalamine
por: Karki, Pratul, et al.
Publicado: (2023)

Coeliac disease: to classify or not to classify – that is the question!
por: Ensari, Arzu
Publicado: (2016)

What’s in a Name? Michael N. Marsh, BTh, DPhil, DM, DSc, FRCP
por: Ensari, Arzu
Publicado: (2021)

Validity and reliability of the Turkish version of the Cold Intolerance Symptom Severity Questionnaire
por: TÖRE, Nurten Gizem, et al.
Publicado: (2019)

Posterior reversible encephalopathy syndrome with PLEDs-plus due to mesalamine
por: Cherian, Ajith, et al.
Publicado: (2014)

Red-Brown Urine Discolouration in Two Patients Taking Mesalamine
por: Smeets, Tim, et al.
Publicado: (2016)

Mesalamine-Induced Myopericarditis: A Case Report and Literature Review
por: Taha, Mohamed E., et al.
Publicado: (2019)

Treatment of lichen planus pemphigoides with mesalamine: novel use of this drug()
por: Gandhi, Vijay, et al.
Publicado: (2022)

Effectiveness of Mesalamine in Patients With Ulcerative Colitis: A Systematic Review
por: Santos, Yurianna, et al.
Publicado: (2023)

Growth, tolerance and safety outcomes with use of an extensively hydrolyzed casein-based formula in infants with cow’s milk protein allergy
por: Kansu, Aydan, et al.
Publicado: (2023)

High- and Low-Dose Oral Delayed-Release Mesalamine in Children With Mild-to-Moderately Active Ulcerative Colitis
por: Winter, Harland S., et al.
Publicado: (2014)

Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis
por: Kedia, Prashant, et al.
Publicado: (2007)

Development and Validation of Spectrophotometric Methods for the Estimation of Mesalamine in Tablet Dosage Forms
por: Patel, KM, et al.
Publicado: (2010)

Dissolution of Commercially Available Mesalamine Formulations at Various pH Levels
por: Tenjarla, Srini
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ehpirpqhmg5inmcs0rhpo1mrh5